Advertisement Cayenne secures $15 million in series C financing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cayenne secures $15 million in series C financing

Cayenne Medical, a privately held sports medicine company based in Scottsdale, Arizona has closed a $15 million series C financing led by Investor Growth Capital.

Other participating investors include SplitRock Partners, MB Venture Partners and a group of accredited private individuals. Stephen Campe, managing director of IGC, has joined Cayenne’s board in connection with the financing. This financing round brings Cayenne’s total private equity investment to $32 million.

James Hart, president and CEO of Cayenne, said: “This successful round of financing will enable us to expand our sales and distribution footprint and further support the continued roll-out of our AperFix System. In addition, we remain committed to serving our growing physician customer base by developing and commercializing a full line of sports medicine products.”